Correlation Between Mydecine Innovations and Tauriga Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Tauriga Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Tauriga Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Tauriga Sciences, you can compare the effects of market volatilities on Mydecine Innovations and Tauriga Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Tauriga Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Tauriga Sciences.

Diversification Opportunities for Mydecine Innovations and Tauriga Sciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mydecine and Tauriga is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Tauriga Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tauriga Sciences and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Tauriga Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tauriga Sciences has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Tauriga Sciences go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Tauriga Sciences

If you would invest  0.40  in Mydecine Innovations Group on December 21, 2024 and sell it today you would lose (0.03) from holding Mydecine Innovations Group or give up 7.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Mydecine Innovations Group  vs.  Tauriga Sciences

 Performance 
       Timeline  
Mydecine Innovations 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.
Tauriga Sciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tauriga Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Tauriga Sciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Mydecine Innovations and Tauriga Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mydecine Innovations and Tauriga Sciences

The main advantage of trading using opposite Mydecine Innovations and Tauriga Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Tauriga Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tauriga Sciences will offset losses from the drop in Tauriga Sciences' long position.
The idea behind Mydecine Innovations Group and Tauriga Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine